UNASSIGNED: ABSTRACT Background: Our goal was to perform a systematic review of the literature on the use of modern inhalational anesthetic agents for refractory @entity159 and their impact on @entity410 control. Methods: All articles from MEDLINE, BIOSIS, EMBASE, Global Health, HealthStar, Scopus, Cochrane Library, the International Clinical Trials Registry Platform (inception to March 2014), reference lists of relevant articles, and gray literature were searched. The strength of evidence was adjudicated using both the Oxford and Grading of Recommendation Assessment Development and Education methodology by two independent reviewers. Results: Overall, 19 studies were identified, with 16 manuscripts and 3 meeting abstracts. A total of 46 @entity1 were treated. Adult (n=28) and pediatric @entity1 (n=18) displayed 92.9% and 94.4% @entity410 control with treatment, respectively. @entity5161 was used in the majority of cases. @entity551 was the only complication described. Conclusions: Oxford level 4, Grading of Recommendation Assessment Development and Education D evidence exists to support the use of @entity5161 in refractory @entity159 to obtain burst suppression. Insufficient data exist to comment on the efficacy of @entity10233 and @entity8506 at this time.

Modern Inhalational Anesthetics for Refractory XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure'] @entity10233 :: ('MESH:C053562', 'Chemical') :: ['desflurane'] @entity8506 :: ('MESH:D014978', 'Chemical') :: ['xenon'] @entity5161 :: ('MESH:D007530', 'Chemical') :: ['Isoflurane', 'isoflurane'] @entity551 :: ('MESH:D007022', 'Disease') :: ['Hypotension'] @entity159 :: ('MESH:D013226', 'Disease') :: ['status epilepticus']
@entity159 :: (MESH:D013226,Disease) :: ['Status Epilepticus']
